 Connection
Lisa Maier to Longitudinal Studies
This is a "connection" page, showing publications Lisa Maier has written about Longitudinal Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.499 |
|
|
|
-
Bhargava M, Crouser ED, Barkes BQ, Weise DO, Perlman DM, Epperson LE, Griffin TJ, Jagtap PD, Mehta S, Li L, Leach SM, Maier LA. Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progression. BMJ Open. 2026 Apr 29; 16(4):e119604.
Score: 0.139
-
Bhargava M, Weise DO, Barkes BQ, Jagtap PD, Mehta S, Lock EF, Kakoty B, Perlman DM, Dincer EH, Restrepo CI, Griffin TJ, Fingerlin TE, Li L, King-Biggs M, Maier LA. Comprehensive proteomic classifier for molecular characterisation of pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to evaluate bronchoalveolar fluid and cell diagnostic and prognostic biomarkers of pulmonary sarcoidosis. BMJ Open. 2026 Apr 28; 16(4):e118207.
Score: 0.139
-
Middleton DC, Mayer AS, Lewin MD, Mroz MM, Maier LA. Interpreting borderline BeLPT results. Am J Ind Med. 2011 Mar; 54(3):205-9.
Score: 0.047
-
Sato H, Silveira L, Spagnolo P, Gillespie M, Gottschall EB, Welsh KI, du Bois RM, Newman LS, Maier LA. CC chemokine receptor 5 gene polymorphisms in beryllium disease. Eur Respir J. 2010 Aug; 36(2):331-8.
Score: 0.045
-
Knoll RL, Brauny MM, Robert E, Cloos L, Waser L, Hilbert K, Ulmer N, Hillen B, Birkner T, Bartolomaeus TUP, Nitsche O, Jarquín-Díaz VH, Lynch S, Gehring S, Maier L, Poplawska K, Forslund-Startceva SK. CFTR modulator therapy drives microbiome restructuring through improved host physiology in cystic fibrosis: the IMMProveCF phase IV trial. Nat Commun. 2025 Nov 18; 16(1):10111.
Score: 0.034
-
Hena KM, Barkes B, Heinrich F, Kogan R, Strykowski RK, Obi ON, Judson MA, Maier LA, Patterson KC. An Inventory of Clinical Sarcoidosis Status in the United States. Chest. 2026 Jan; 169(1):159-173.
Score: 0.033
-
Newman LS, Mroz MM, Balkissoon R, Maier LA. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med. 2005 Jan 01; 171(1):54-60.
Score: 0.031
-
Silveira LJ, Strand M, Van Dyke MV, Mroz MM, Faino AV, Dabelea DM, Maier LA, Fingerlin TE. Clinical tool for disease phenotyping in granulomatous lung disease. PLoS One. 2017; 12(11):e0188119.
Score: 0.019
-
Mroz MM, Maier LA, Strand M, Silviera L, Newman LS. Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease. Am J Ind Med. 2009 Oct; 52(10):762-73.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|